calendar
7 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 3,921 phase readout · 2,127 8k filing · 2,000 device pma
next 91 dayslessmore
MonWedFri
7 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 3,921 phase readout · 2,127 8k filing · 2,000 device pma
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.